• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Use of physiotherapy records to monitor the efficacy of a poliomyelitis vaccination programme in Ilorin, Nigeria 1981-1988.

作者信息

Babaniyi O A, Yeye-Agba B, Parakoyi D B

机构信息

Ministry of Health, Kwara State, Nigeria.

出版信息

Trop Doct. 1991 Apr;21(2):69-72. doi: 10.1177/004947559102100210.

DOI:10.1177/004947559102100210
PMID:1871883
Abstract

During the 8 years of a poliomyelitis control programme in Ilorin Local Government Area, Nigeria, a maximum of 85% of children aged 12-23 months were estimated to have received three doses of trivalent oral polio vaccine (TOPV). The estimated incidence of paralytic poliomyelitis decreased by 65%, suggesting a low vaccine efficacy of approximately 76% for the currently used TOPV. A more detailed study of TOPV efficacy (eg case control or cohort study) is required, however, to provide a more accurate estimate. Similar low-cost efforts at documenting the impact of TOPV on the incidence of poliomyelitis, using physiotherapy clinics as independent sentinels, are needed from many other centres. To increase the efficacy of the primary series of TOPV in Nigeria, the number of doses constituting the primary series should be increased to four (including one at birth), as recommended by the World Health Organization.

摘要

相似文献

1
Use of physiotherapy records to monitor the efficacy of a poliomyelitis vaccination programme in Ilorin, Nigeria 1981-1988.
Trop Doct. 1991 Apr;21(2):69-72. doi: 10.1177/004947559102100210.
2
Monitoring impact of oral poliovirus vaccine on poliomyelitis trends from physiotherapy records, Ilorin, Nigeria, 1981-1988.
East Afr Med J. 1991 Aug;68(8):642-8.
3
Combined live and inactivated poliovirus vaccine to control poliomyelitis in a developing country--five years after.联合使用活疫苗和灭活脊髓灰质炎病毒疫苗在一个发展中国家控制脊髓灰质炎——五年之后
Dev Biol Stand. 1986;65:137-43.
4
The polio endgame.脊髓灰质炎的终结之战。
Hum Vaccin Immunother. 2014;10(7):2106-8. doi: 10.4161/21645515.2014.981115.
5
Cessation of Trivalent Oral Poliovirus Vaccine and Introduction of Inactivated Poliovirus Vaccine - Worldwide, 2016.三价口服脊髓灰质炎疫苗停用和灭活脊髓灰质炎疫苗引入-全球,2016 年。
MMWR Morb Mortal Wkly Rep. 2016 Sep 9;65(35):934-8. doi: 10.15585/mmwr.mm6535a3.
6
The global switch from trivalent oral polio vaccine (tOPV) to bivalent oral polio vaccine (bOPV): facts, experiences and lessons learned from the south-south zone; Nigeria, April 2016.全球从三价口服脊髓灰质炎疫苗(tOPV)向二价口服脊髓灰质炎疫苗(bOPV)的转换:来自南南区域(尼日利亚)的事实、经验与教训,2016年4月
BMC Infect Dis. 2018 Jan 27;18(1):57. doi: 10.1186/s12879-018-2963-6.
7
Effect of substituting IPV for tOPV on immunity to poliovirus in Bangladeshi infants: An open-label randomized controlled trial.用灭活脊髓灰质炎疫苗替代口服脊髓灰质炎减毒活疫苗对孟加拉国婴儿脊髓灰质炎病毒免疫力的影响:一项开放标签随机对照试验。
Vaccine. 2016 Jan 12;34(3):358-66. doi: 10.1016/j.vaccine.2015.11.046. Epub 2015 Nov 28.
8
Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial.二价 1 型和 3 型口服脊髓灰质炎疫苗的免疫原性:一项随机、双盲、对照试验。
Lancet. 2010 Nov 13;376(9753):1682-8. doi: 10.1016/S0140-6736(10)61230-5. Epub 2010 Oct 25.
9
Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.在智利婴儿中单独使用或与二价口服脊髓灰质炎疫苗序贯使用灭活脊髓灰质炎病毒疫苗:一项随机、对照、开放性标签、四期、非劣效性研究。
Lancet Infect Dis. 2015 Nov;15(11):1273-82. doi: 10.1016/S1473-3099(15)00219-4. Epub 2015 Aug 26.
10
Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).美国的脊髓灰质炎预防:采用先接种灭活脊髓灰质炎病毒疫苗后接种口服脊髓灰质炎病毒疫苗的序贯接种程序。免疫实践咨询委员会(ACIP)的建议
MMWR Recomm Rep. 1997 Jan 24;46(RR-3):1-25.